BeStock  
Stocks › Biotechnology › VSTM

Verastem VSTM

US equityMarket cap rank #3309Biotechnology
$6.33 −$0.53 (-7.73%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $6.39 +0.95%
Open$6.63
Prev close$6.86
Day range$6.25 – $6.82
Volume3.25M
Market cap$797.67M
P/E (TTM)–
Dividend yield–

Earnings

Average move on report day±9.3%last 16 reports
Closed higher8 of 1650% of the time
Best reaction+19.9%
Worst reaction-28.0%

Stock move on the day after each report

+0.0%2016/Q3+9.9%2016/Q4+3.4%2018/Q4-28.0%2019/Q1-11.9%2019/Q2-13.6%2019/Q3+19.9%2025/Q2+3.2%2025/Q3+5.9%2025/Q4-13.6%2026/Q1+14.0%2026/Q2-10.3%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q35 Nov 2026After Market±17.9%-10.34%Within range
2026/Q26 Aug 2026After Market±24.9%+14.04%Within range
2026/Q17 May 2026After Market±24.5%-13.60%Within range
2025/Q44 Mar 2026None±26.7%+5.85%Within range
2025/Q34 Nov 2025After Market±32.6%+3.16%Within range
2025/Q27 Aug 2025After Market±25.1%+19.93%Within range
2019/Q329 Oct 2019After Market–-13.60%–
2019/Q21 Aug 2019After Market–-11.95%–
2019/Q19 May 2019After Market–-28.04%–
2018/Q412 Mar 2019After Market–+3.40%–
2016/Q423 Mar 2017After Market–+9.93%–
2016/Q37 Nov 2016None–+0.00%–
2015/Q43 Mar 2016Pre Market–+13.49%–
2013/Q46 Mar 2014Pre Market–-0.28%–
2012/Q427 Mar 2013Pre Market–+0.10%–
2011/Q414 Mar 2012Pre Market–-1.79%–

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Latest reported quarter: Q3, ended Sep 2026

Revenue$24.01M+113.6% YoY
Operating profit-$75.22M-84.8% YoY
Net profit-$74.72M+24.2% YoY
Diluted EPS-$0.74+45.2% YoY
Free cash flow-$41.09M+7.6% YoY
Operating cash flow-$33.59M

Revenue, last 8 quarters

$0.0Dec '24$0.0Mar '25$2.1MJun '25$11.2MSep '25$17.5MDec '25$18.7MMar '26$40.1MJun '26$24.0MSep '26

Net profit, last 8 quarters

$-64.6MDec '24$-52.1MMar '25$-25.9MJun '25$-98.5MSep '25$-32.9MDec '25$-36.6MMar '26$-34.7MJun '26$-74.7MSep '26

Profitability & balance sheet

Gross margin86.1%
Operating margin-193.7%
Net margin-178.4%
Return on assets-88.0%
Current ratio1.93
Liabilities / assets95.6%
Cash & investments$172.80M
Total debt$127.79M
Net cash (debt)$45.01M

Discussion

No comments yet — be the first to weigh in on VSTM.

Sign in to join the discussion.

Scroll to Top